Brief: Crescita Therapeutics announces acquisition of Alyria skincare products
08/08/2017 12:30
Aug 8 (Reuters) - Crescita Therapeutics Inc CTX.TO
* Crescita Therapeutics announces acquisition of Alyria
skincare products
* Crescita Therapeutics Inc - Crescita purchased Alyria for
cash consideration of $1.7 million
* Crescita Therapeutics Inc - Deal immediately accretive to
revenue and gross margin for Crescita
* Crescita - Deal also includes a royalty agreement based on
a threshold of annual net sales of Alyria over a 9-year period
starting in 2020
Source text for Eikon: ID:nPn6RNC3Va
Further company coverage: CTX.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium